These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10493131)

  • 1. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera.
    Sanchez-Campillo M; Bini L; Comanducci M; Raggiaschi R; Marzocchi B; Pallini V; Ratti G
    Electrophoresis; 1999 Aug; 20(11):2269-79. PubMed ID: 10493131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of Chlamydia trachomatis proteins by immobiline-polyacrylamide two-dimensional electrophoresis: spot identification by N-terminal sequencing and immunoblotting.
    Bini L; Sanchez-Campillo M; Santucci A; Magi B; Marzocchi B; Comanducci M; Christiansen G; Birkelund S; Cevenini R; Vretou E; Ratti G; Pallini V
    Electrophoresis; 1996 Jan; 17(1):185-90. PubMed ID: 8907538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.
    Forsbach-Birk V; Simnacher U; Pfrepper KI; Soutschek E; Kiselev AO; Lampe MF; Meyer T; Straube E; Essig A
    Clin Microbiol Infect; 2010 Aug; 16(8):1237-44. PubMed ID: 19723133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular biology and diagnostics of Chlamydia trachomatis.
    Birkelund S
    Dan Med Bull; 1992 Aug; 39(4):304-20. PubMed ID: 1526183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of Brucella ovis immunogenic proteins using two-dimensional electrophoresis and immunoblotting.
    Teixeira-Gomes AP; Cloeckaert A; Bézard G; Bowden RA; Dubray G; Zygmunt MS
    Electrophoresis; 1997 Aug; 18(8):1491-7. PubMed ID: 9298663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an iron-responsive protein that is antigenic in patients with Chlamydia trachomatis genital infections.
    Raulston JE; Miller JD; Davis CH; Schell M; Baldwin A; Ferguson K; Lane H
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):569-76. PubMed ID: 17991015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological response to pgp3 protein in animal and human chlamydial infections.
    Donati M; Laroucau K; Storni E; Mazzeo C; Magnino S; Di Francesco A; Baldelli R; Ceglie L; Renzi M; Cevenini R
    Vet Microbiol; 2009 Mar; 135(1-2):181-5. PubMed ID: 18945555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB.
    Barker CJ; Beagley KW; Hafner LM; Timms P
    Vaccine; 2008 Mar; 26(10):1285-96. PubMed ID: 18261829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of two novel proteins in Chlamydia trachomatis during natural infection.
    Myers GS; Grinvalds R; Booth S; Hutton SI; Binks M; Kemp DJ; Sriprakash KS
    Microb Pathog; 2000 Aug; 29(2):63-72. PubMed ID: 10906261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different humoral immune response to Chlamydia trachomatis major outer membrane protein variable domains I and IV in Chlamydia-infected patients with or without reactive arthritis.
    Bas S; Scieux C; Vischer TL
    Arthritis Rheum; 1999 May; 42(5):942-7. PubMed ID: 10323449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis serology: diagnostic value of outer membrane protein 2 compared with that of other antigens.
    Bas S; Muzzin P; Vischer TL
    J Clin Microbiol; 2001 Nov; 39(11):4082-5. PubMed ID: 11682533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping and identification of Brucella melitensis proteins by two-dimensional electrophoresis and microsequencing.
    Teixeira-Gomes AP; Cloeckaert A; Bézard G; Dubray G; Zygmunt MS
    Electrophoresis; 1997 Jan; 18(1):156-62. PubMed ID: 9059838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
    J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human antibody and antigen response to IncA antibody of Chlamydia trachomatis.
    Tsai PY; Hsu MC; Huang CT; Li SY
    Int J Immunopathol Pharmacol; 2007; 20(1):156-61. PubMed ID: 17346439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
    Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a plasmid gene of Chlamydia trachomatis encoding a novel 28 kDa antigen.
    Comanducci M; Cevenini R; Moroni A; Giuliani MM; Ricci S; Scarlato V; Ratti G
    J Gen Microbiol; 1993 May; 139(5):1083-92. PubMed ID: 8336105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capture-ELISA: a new assay for the detection of immunoglobulin M isotype antibodies using Chlamydia trachomatis antigen.
    Poussin M; Fuentes V; Corbel C; Prin L; Eb F; Orfila J
    J Immunol Methods; 1997 May; 204(1):1-12. PubMed ID: 9202704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-dimensional electrophoretic analysis of the protein family at 90 kDa of abortifacient Chlamydia psittaci.
    Giannikopoulou P; Bini L; Simitsek PD; Pallini V; Vretou E
    Electrophoresis; 1997 Oct; 18(11):2104-8. PubMed ID: 9420176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
    Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the disulfide bonds and free cysteine residues of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
    Yen TY; Pal S; de la Maza LM
    Biochemistry; 2005 Apr; 44(16):6250-6. PubMed ID: 15835913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.